Feasibility Study for Prospective Diet and Lifestyle Cohorts in Delhi, Kerala, and Kolkota, India

NCT ID: NCT00341536

Last Updated: 2018-04-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

4044 participants

Study Classification

OBSERVATIONAL

Study Start Date

2004-06-17

Study Completion Date

2013-11-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This pilot study will examine the potential for health, diet and lifestyle research in Delhi, Kerala, and Kolkota, India. It will: 1) evaluate the adequacy of the existing infrastructure for a large-scale epidemiologic investigation and follow-up; 2) obtain a characterization of the Indian diet; 3) determine study end-points; 4) evaluate the feasibility of collecting and analyzing biologic samples within India; and 5) evaluate the ability of centers to recruit subjects and collect data.

Indian men and women between 35 and 70 years of age who have resided in the study area (Delhi, Kerala, or Kolkota) for at least 1 year may be eligible for this study. Participants will undergo the following tests and procedures:

Part A: Diet and Lifestyle (2 visits)

* Questionnaires on medical history and treatment practices, including questions on reproductive history
* Brief medical examination
* Body measurements, including height, weight, forearm circumference, thighs, hips, stomach, skin thickness of the back and triceps (back of the arms)
* Blood draw for research, including studies of gene changes that affect the way the body uses nutrients
* Collection of toenail clippings for research tests
* Interview about: 1) dietary habits and understanding of the relationship of diet to health; 2) lifestyle, work, and family health; and 3) moving history (how often subject has moved in the past 5 years, addresses of past homes, and plans for future moves)

Part B: Understanding Diet (6 visits)

* Interview at each visit about food and drink consumed the day before the interview
* 2 blood draws
* 24-hour urine collection
* Physical activity monitor. The subject wears a small device placed on the belt or waist of the pants for a specified time to measure the amount of movement performed.

Part C: Medical Follow-up Patterns (1 visit)

-Answer questions about medical history, treatment practices, and dietary habits

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background

Cancer research in developing countries has not received adequate attention in spite of having great potential to improve our understanding of genes and environmental exposures such as diet in the etiology of cancer. Specifically, an Indian dietary cohort would substantially expand the intake range and variety of different foods and lifestyles that have not been adequately explored, e.g., spices, type of oils, lentils, vegetarianism (tied to religion rather than healthy life-style ), and types of physical activities. Indians also have distinct cancer incidence patterns. Establishing a cohort will allow us to study multiple cancer outcomes as well as other disease end-points (e.g., cardiovascular disease and diabetes), and it will avoid potential bias resulting from differential recall of past diet by subjects, a critical concern in case-control studies that assess nutritional intake. As measurement of various biological markers will be an integral component of this study, it will be important to collect biological specimens prior to illness and treatment. This is particularly important in India as cases may present with late stage disease.

Because a study of this magnitude and complexity has not been carried out in India, I have proposed a pilot study to determine the feasibility of conducting a large cohort study in India. The pilot study consists of three parts: 1) evaluation of logistical issues; 2) characterization of the diet; and 3) evaluation of issues related to follow-up and end-point ascertainment. In Part A of this pilot study there will be 4,000 subjects. This part of the study will be evaluated for logistical issues, including questionnaire administration, collection, storage, and analysis. Response rates for questionnaires, collection of biospecimens and the centers ability to carry out the proposed research will be evaluated as well. Part B of the pilot study consists of a characterization of Indian diet to determine within- and between-person variability in intake in a subset of 1,400 subjects; an evaluation to determine whether Indians can estimate food quantities accurately; assess the degree of measurement error in selected nutrients; and ascertain whether using multiple forms of intake instruments in combination with biomarkers may categorize intake with less error. In Part C of the pilot study, issues related to follow-up and end-point ascertainment in 1200 subjects will be evaluated. In addition, an evaluation of the likelihood of cancers and other chronic diseases remaining completely undiagnosed owning to lack of access to health care; assess movement pattern and traceability of Indian populations; as well as an evaluation of the cancer registry coverage and determine whether supplementary activities are required.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Diseases

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Once a subject is identified, their eligibility for study participation will be determined based on the following:

Age between 35-70 years.

Use or would consider using certain medical centers/hospitals in the catchment area.

Resided in study area a minimum period of one year.

Must speak Hindi, Punjabi or English.

Female subjects cannot be pregnant.

Exclusion Criteria

Children will be excluded from the study.

We will exclude persons with any physical ailments preventing them from study participation, and with recent chronic or other serious diseases or conditions that have made them alter their diet. This is likely to include cancer as well as cardiovascular disease or diabetes and also some infectious conditions.

Participants will be terminated from the study if they move outside of the study area.
Minimum Eligible Age

35 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rashmi Sinha, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

National Cancer Institute (NCI)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Initiative for Cardiovascular Health Research in the Developing Countries

New Delhi, , India

Site Status

Countries

Review the countries where the study has at least one active or historical site.

India

References

Explore related publications, articles, or registry entries linked to this study.

Krishnaswamy K, Polasa K. Diet, nutrition & cancer--the Indian scenario. Indian J Med Res. 1995 Nov;102:200-9.

Reference Type BACKGROUND
PMID: 8675239 (View on PubMed)

Krishnaswamy K, Raghuramulu N. Bioactive phytochemicals with emphasis on dietary practices. Indian J Med Res. 1998 Nov;108:167-81.

Reference Type BACKGROUND
PMID: 9863273 (View on PubMed)

Krishnaswamy K, Goud VK, Sesikeran B, Mukundan MA, Krishna TP. Retardation of experimental tumorigenesis and reduction in DNA adducts by turmeric and curcumin. Nutr Cancer. 1998;30(2):163-6. doi: 10.1080/01635589809514657.

Reference Type BACKGROUND
PMID: 9589436 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

04-C-N219

Identifier Type: -

Identifier Source: secondary_id

999904219

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.